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Abstract
Background: In the 1950s, Reed and coworkers discovered an enzyme activity in Streptococcus faecalis (Enterococcus
faecalis) extracts that inactivated the Escherichia. coli and E. faecalis pyruvate dehydrogenase complexes through cleavage
of the lipoamide bond. The enzyme that caused this lipoamidase activity remained unidentified until Jiang and Cronan
discovered the gene encoding lipoamidase (Lpa) through the screening of an expression library. Subsequent cloning and
characterization of the recombinant enzyme revealed that lipoamidase is an 80 kDa protein composed of an amidase
domain containing a classic Ser-Ser-Lys catalytic triad and a carboxy-terminal domain of unknown function. Here, we show
that the amidase domain can be used as an in vivo probe which specifically inactivates lipoylated enzymes.
Methodology/Principal Findings: We evaluated whether Lpa could function as an inducible probe of a-ketoacid
dehydrogenase inactivation using E. coli as a model system. Lpa expression resulted in cleavage of lipoic acid from the three
lipoylated proteins expressed in E. coli, but did not result in cleavage of biotin from the sole biotinylated protein, the biotin
carboxyl carrier protein. When expressed in lipoylation deficient E. coli, Lpa is not toxic, indicating that Lpa does not
interfere with any other critical metabolic pathways. When truncated to the amidase domain, Lpa retained lipoamidase
activity without acquiring biotinidase activity, indicating that the carboxy-terminal domain is not essential for substrate
recognition or function. Substitution of any of the three catalytic triad amino acids with alanine produced inactive Lpa
proteins.
Conclusions/Significance: The enzyme lipoamidase is active against a broad range of lipoylated proteins in vivo, but does
not affect the growth of lipoylation deficient E. coli. Lpa can be truncated to 60% of its original size with only a partial loss of
activity, resulting in a smaller probe that can be used to study the effects of a-ketoacid dehydrogenase inactivation in vivo.
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Introduction
The cofactor lipoic acid is necessary for the oxidative decarbox-
ylation of 2-ketoacids, an activity essential to the tricarboxylic acid
cycle, amino acid metabolism, heme biosynthesis, and other
metabolic processes. Oxidative decarboxylation is carried out by
large, multisubunit complexes, including pyruvate dehydrogenase
(PDH), a-ketoglutarate dehydrogenase (KDH), and branched chain
a-ketoacid dehydrogenase (BCDH) [1,2]. These complexes are
composed of three subunits, the E1 a-ketoacid dehydrogenase, the
E2 transacetylase, and the E3 dihydrolipoyldehydrogenase [1,3].
The carbonyl of lipoic acid is attached to the e-amino group of
specific lysine residues on the E2 subunits, forming an amide bond
[4]. Lipoic acid plays two critical roles in a-ketoacid dehydrogenase
complexes. It is reductively acylated by the E1 subunit and
subsequently functions as a swinging arm to transfer the covalently
bound acyl group to the active site of the E3 subunit [1]. A fourth
enzyme complex, called the glycine cleavage complex (GCV),
catalyzes similar reactions, but the nomenclature is different and the
subunit containing lipoic acid is referred to as the H-protein [5,6].
In the 1950s, while studying the role of lipoic acid in the
activation of the Streptococcus faecalis (now Enterococcus faecalis) PDH,
Reed and coworkers discovered a partially purified enzyme
activity from E. faecalis that inactivated the Escherichia coli and E.
faecalis PDH and caused the release of free lipoic acid [7]. Further
purification and analysis of the unidentified protein, called
lipoamidase (Lpa), established that the enzyme cleaved lipoic acid
from a-ketoacid dehydrogenases and lipoic acid amide and ester
small molecules but had little to no activity on e-N-biotinyl-L-
lysine (biotinyl-lysine), e-N-acetyl-L-lysine, or e-N-benzoyl-L-lysine
[8]. The gene and protein that were the source of this activity
remained unknown for 50 years, until Jiang and Cronan identified
the Lpa gene by screening an expression library for Lpa activity
[9]. The Lpa gene encodes an 80 kDa protein with an N-terminal
amidase domain featuring a characteristic Ser-Ser-Lys catalytic
triad and a C-terminal domain of unknown function [9].
Overexpression of Lpa in E. coli and purification of the enzyme
to near homogeneity enabled further study of Lpa activity. The
purified enzyme inactivated E. coli lipoyl proteins and cleaved
lipoate from lipoyl-lysine. Purified Lpa also cleaved biotin from
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lipoate from lipoyl-lysine.
Since its discovery in partially purified E. faecalis extracts 50
years ago, lipoamidase activity has played an important role in
establishing lipoate as an essential cofactor for a-ketoacid
dehydrogenase activity and in studies of E. coli lipoic acid
biosynthesis [2]. The recent identification of the gene encoding
Lpa now makes it possible to use Lpa as a probe to study the
effects of a-ketoacid dehydrogenase inactivation in vivo.W e
evaluated the activity and specificity of Lpa in E. coli using an
inducible expression system. Lpa cleaved radiolabeled lipoic acid
from all three lipoylated proteins in E. coli, and inhibited bacterial
growth. Substitution of any of the three catalytic triad amino acids
to alanine yielded inactive enzyme in vivo. Expression of Lpa in vivo
does not affect biotinylation of the E. coli acetyl-CoA carboxylase
(ACCase), demonstrating that Lpa is a specific probe for lipoate
disruption despite its broad substrate specificity among lipoylated
proteins. Consequently, expression of Lpa in lipoate deficient cells
is not toxic. Lpa retains activity and specificity when truncated to
its 47 kDa amidase domain, resulting in a small, soluble probe that
is amenable to heterologous expression.
Materials and Methods
Cloning of Lpa and Lpa mutants
All primers used for this work are listed in Table 1. Primers
were obtained from Invitrogen, endonucleases were purchased
from New England Biolabs, and all PCR reactions were
performed with TurboPfu DNA polymerase (Stratagene). The
gene encoding lipoamidase from E. faecalis strain V583 was
amplified by PCR from plasmid pYFJ62 (a kind gift from John
Cronan) [9] using the Lpa primers. The PCR product was
digested with BamHI and SalI followed by ligation into the pLZ
expression vector [10] (MalE gene of pMAL_cHT [11] replaced
with the amino acids MRGS) to generate plasmid pMS007.
Constructs expressed in the pLZ vector are produced with an N-
terminal hexa-histidine tag composed of the amino acids
MRGSHHHHHHEFGS. Active site and truncation mutants of
Lpa were generated by site-directed mutagenesis with the
QuickChange mutagenesis kit (Stratagene) using the manufactur-
er’s directions. For the active site mutants, plasmid pMS007 was
used with the primers K159A, S235A, and S259A to produce
pMS012, pMS029, and pMS008, respectively. For the truncation
mutants, the primers t471 and t521 were used to generate
constructs that replaced amino acids 471 and 521 with stop
codons, resulting in plasmids pMS009 and pMS010, respectively.
The PCR products from all mutagenesis reactions were digested
with DpnI and transformed into TOP10 cells (Invitrogen).
Plasmids isolated from individual colonies were sequenced to
confirm all lipoamidase mutations.
Western blotting
Proteins were separated on 4–12% sodium-dodecyl sulfate
polyacrylamide gels (SDS-PAGE) (Invitrogen) and transferred to
nitrocellulose membranes. Membranes were probed with an
antibody that specifically recognizes MRGSHis6 and is conjugated
to horseradish peroxididase (HRP) (1:1000, Qiagen), rabbit
antiserum specific for lipoylated proteins (1:10,000, Calbiochem),
streptavidin-HRP (1:1000, Calbiochem), or rabbit antiserum
specific for E. coli HSP70 (1:20,000, a gift from Roger McMacken).
When necessary, HRP conjugated donkey anti-rabbit serum
(1:5000, GE healthcare) was used as a secondary probe. HRP-
conjugated probes were detected with the Supersignal West Pico
chemiluminescence kit (Pierce). Blots that were subject to more
than one western blot experiment were stripped with 4%
trichloroacetic acid twice for 15 minutes between analyses.
Densitometry analyses were conducted in ImageJ, and lipoylation
and biotinylation levels were determined by normalizing signals
for these cofactors to anti-HSP70 signal. Relative lipoylation levels
were obtained by dividing the normalized signal for Lpa samples
by the normalized signal for samples expressing vector alone.
Error bars represent the standard error of the mean between three
or more independent western blots.
Uptake and incorporation of
35S-lipoic acid in cells
expressing Lpa and Lpa S259A
The plasmids pMS007 and pMS008 were transformed into
KER176 E. coli (lipA::TN1000dkan) [12]. The KER176 strain (a
gift from John Cronan) does not contain a functional lipoate
synthase, and is thus a lipoate auxotroph. E. coli KER176
harboring the plasmid pMS007 or pMS008 were cultured
overnight in LB media supplemented with 25 ng/ml lipoic acid,
100 mg/ml carbenicillin, and 50 mg/ml kanamycin. Cells were
diluted 1:10,000 in a modified E minimal media [13] supple-
Table 1. Primer sequences.
Primer Sequence (59-39)
Lpa F GGTGGTGGATCCATGTTGGCACAAGAAAGTATACTAG
Lpa R GGTGGTGTCGACTTATCATTTTCTAGTTTTCCTTATATAAATC
K159A 1 GGTGTGCCGCTCTTACTAGCAGGGTTAGGACAATCCTTG
K159A 2 CAAGGATTGTCCTAACCCTGCTAGTAAGAGCGGCACACC
S235A 1 TGGAATCCTAACCATTATTCAGGTGGTGCTTCAGGCGGAGCGCCGG
S235A 2 CCGGCGCTCCGCCTGAAGCACCACCTGAATAATGGTTAGGATTCCA
S259A 1 GAAGTGATGCTGGTGGCGCTATCCGCATCCCTGC
S259A 2 GCAGGGATGCGGATAGCGCCACCAGCATCACTTC
t471 1 TTACTAAAACCAGAACATGCAGCATGATCTAGAAAAATTGATCAATTGTCACCAGCAG
t471 2 CTGCTGGTGACAATTGATCAATTTTTCTAGATCATGCTGCATGTTCTGGTTTTAGTAA
t521 1 AAAGTGTACCAACTTACGTTTCAAAATAGTCTAGACCTTTGGGGATTCAATTTAATAGTG
t521 2 CACTATTAAATTGAATCCCCAAAGGTCTAGACTATTTTGAAACGTAAGTTGGTACACTTT
doi:10.1371/journal.pone.0007392.t001
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lysate, 2 mg/ml thiamine, 7.5 mg/ml ferrous sulfate, 50 mg/ml
kanamycin, and 100 mg/ml carbenicillin. Diluted cells were added
1:50 to 0.5 ml of supplemented minimal media containing
35S-
lipoic acid (10 ng with a specific activity of 34.2 Ci/mmol) [10]
and cultured at 37uC. At OD600=0.6 protein expression was
induced with 0.4 mM IPTG and the cells were cultured for an
additional 10 hours at 20uC. After induction, the cultures were
normalized based on optical density at 600 nm (OD600) and
harvested by centrifugation. Cell pellets were lysed in 1x SDS-
PAGE sample buffer by three cycles of heating for 5 minutes at
95uC followed by 30 seconds of vortexing. Lipoic acid uptake and
retention was measured by scintillation counting of cell lysates.
Lipoic acid incorporation was assessed by separating the cell
lysates on a 4–12% gradient SDS-PAGE gel followed by transfer
to nitrocellulose membrane and analysis by autoradiography.
Differences in levels of lipoic acid incorporation into the PDH,
KDH, and H-protein in cells expressing Lpa compared to cells
expressing Lpa S259A were determined by densitometry analysis
performed with ImageJ.
Assay of Lpa expression and its effect on growth,
lipoylation, and biotinylation
Several growth, lipoylation, and biotinylation experiments were
conducted using BL21-Star(DE3) E. coli (Invitrogen) containing
the pRIL plasmid isolated from BL21-CodonPlus(DE3) cells
(Stratagene). These cells were transformed with the empty
expression vector pLZ, or with pLZ encoding wild type
lipoamidase (pMS007), active site point mutants (pMS008,
pMS012, and pMS029), or the truncation mutants (pMS009
and pMS010). As additional controls, cells were also prepared with
two plasmids (pSP010 and pMS002) encoding unrelated genes
(malonyl-CoA:ACP acyltransferase (MCAT) [14] and ketoacyl-
ACP synthase II (KASII) [15] from Plasmodium falciparum) in the
pMALcHT expression vector [11]. This vector expresses MBP
(Maltose Binding Protein) fusion proteins, but otherwise has an
identical plasmid backbone to that of pLZ. Transformed BL21-
Star(DE3) cells were grown at 37uC and selected on LB-agar plates
containing 100 mg/ml carbenicillin and 35 mg/ml chloramphen-
icol. Colonies were selected in triplicate for each construct and
cultures were grown overnight at 37uC with shaking in LB media
containing 100 mg/ml carbenicillin and 35 mg/ml chloramphen-
icol. The cultures were then diluted to OD600=0.1 in fresh LB
medium with antibiotics and grown for one hour at 37uC. Protein
expression was induced by the addition of 0.4 mM IPTG followed
by 10 hours growth at 37uCo r2 0 uC. The OD600 of the cultures
was measured at 0, 2, 4, 6, and 10 hours post-induction. For each
triplicate set of cultures, the culture with median growth at
10 hours was selected for analysis of protein lipoylation and
biotinylation by western blot (described above). The volume of
cells harvested for analysis was normalized to 400 ml of the culture
with the lowest OD600. The cell pellets were resuspended in 100 ml
of 1X SDS-PAGE sample buffer and lysed as previously described.
The cell lysate was then diluted 1:10 in sample buffer and the
equivalent of 1 ml of culture was run per lane.
Comparison of
35S-lipoic acid incorporation in cells
expressing Lpa active site mutants
Plasmids encoding mutant lipoamidase (pMS008, pMS012, and
pMS029) were transformed into KER176 E. coli to determine
whether anyofthesemutantsdisplaydetectablelipoamidaseactivity.
As controls, empty expression vector pLZ and pSP010 encoding
P. falciparum MCAT (described above) were also transformed into
KER176. Transformed cells were grown overnight in LB medium
supplemented with 10 ng/ml lipoic acid, 100 mg/ml carbenicillin,
and 50 mg/ml kanamycin. Cells were diluted 1:500 in a modified E
minimal media [13] supplemented with 0.4% glucose, 1 mg/ml
vitamin-free casein hydrolysate, 2 mg/ml thiamine, 7.5 mg/ml
ferrous sulfate, 50 mg/ml kanamycin, and 100 mg/ml carbenicillin.
Diluted cells were added 1:50 to 0.5 ml of supplemented minimal
media containing
35S-lipoic acid (7 ng with a specific activity of
34 Ci/mmol) [10] and cultured at 37uC. At OD600=0.4–0.6
protein expression was induced with 0.4 mM IPTG and the cells
were cultured for an additional 6 hours at 20uC. After induction, the
cultures were normalized based on optical density at 600 nm
(OD600)and harvestedbycentrifugation.Cellpelletswerelysedin1x
SDS-PAGE sample buffer by three cycles of heating for 5 minutes at
95uC followed by 30 seconds of vortexing. Lipoic acid incorporation
was assessed by separating the cell lysates on a 4–12% gradient SDS-
PAGE gel followed by transfer to nitrocellulose membrane and
analysis by autoradiography. The incorporation of
35S-lipoic acid
into the E. coli PDH, KDH, and H-protein was determined by
densitometry analysis performed with ImageJ.
Lpa expression in TM136 strain E. coli
Plasmids encoding wild type (pMS007) and active site mutant
(pMS029 and pMS008) Lpa were transformed into lipoylation
deficient TM136 strain E. coli [16]. Colonies were selected on LB-
agar plates supplemented with 2% glucose, 5 mM sodium acetate,
5 mM sodium succinate, 1 g/L vitamin-free casein hydrolysate and
antibiotics (50 mg/ml kanamycin, 7.5 mg/ml tetracycline, and
100 mg/ml carbenicillin). Three colonies were chosen from each
plate and grown to mid-log phase at 37uC in TM136 medium (LB
supplemented with 2% glucose, 5 mM sodium acetate, 5 mM
sodium succinate, 1 g/L vitamin-free casein hydrolysate, 50 mg/ml
kanamycin, 7.5 mg/ml tetracycline, and 100 mg/ml carbenicillin).
These cultures were diluted in the same medium to an OD600 of
0.05 and were each divided into four replicate cultures. These were
allowed to grow at 37uC for 45 minutes after which the four
replicates were used to initiate the growth experiment. Two
replicates were maintained at 37uC and IPTG was added to one
at a final concentration of 0.4 mM. The other two replicates were
maintained at 20uC (with and without IPTG). Optical density
measurements were made at this time point (t=0) and every two
hours thereafter to track the growth of these cultures.
Assay of lipoamidase solubility
The expression and solubility of wild type Lpa and the
truncation mutants Lpat471 and Lpat521 were assessed in BL21-
Star(DE3) cells containing the plasmid pRIL (described above).
Cultures harboring each construct were grown to an OD600 of 0.6
at 37uC in 100 ml of LB medium containing 100 mg/ml
carbenicillin and 35 mg/ml chloramphenicol. At this point, protein
expression was induced with 0.4 mM IPTG and each culture was
split with 50 ml maintained at 37uC for four hours, and 50 ml
maintained at 20uC for 10 hours. At the end of the induction
period, 10 ml was removed from the culture with the lowest
OD600 and harvested by centrifugation. Equivalent amounts
(based on optical density) were harvested from the other cultures,
and the cell pellets were lysed by incubation in 1 ml of Bug Buster
reagent (Novagen) containing 1 mg/ml lysozme and 10 mg/ml
DNaseI for 10 minutes at room temperature. The insoluble
fraction was isolated by centrifugation of whole cell lysate at
16,000 g for 10 minutes and resolubilized in 1 ml of 6 M urea.
Protein samples containing 0.5 ml of the soluble or insoluble
fraction were separated by SDS-PAGE and analyzed by anti-
MRGSHis6 western blot, as described above.
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The amino acid sequences of lipoylated and biotinylated
proteins in E. coli, Saccharomyces cerevisiae, Homo sapiens, and P.
falciparum were obtained from the NCBI database. The bacterial
genome resource J. Craig Venter Institute was then used to
identify lipoylated proteins in E. faecalis through BLAST homology
searches with the E. coli and S. cerevisiae lipoylated proteins. Amino
acid sequences were aligned using CLUSTAL W [17].
Results
Lpa expression in vivo
We cloned the V583 lipoamidase gene into a derivative of the
pMAL vector that produces His6-Lpa and expressed the enzyme
in BL21-Star(DE3) cells. We observed that transformed cells were
viable when grown at 37uC but not after overnight storage at 4uC,
perhaps due to increased sensitivity of cells to leaky expression of
the toxic lpa gene at low temperature. To determine if Lpa
expressed in vivo is active at the physiologic temperature 37uC and
to compare the effects of lipoamidase expression at physiological
and sub-physiological temperatures, cell growth and lipoamidase
levels were tracked over the course of ten-hour inductions at 37uC
and 20uC. E. coli expressing Lpa at 37uC exhibited slow growth
during the first four hours of induction but attained a cell density
similar to that of the control culture by the end of the induction
period (Figure 1A). In contrast, cultures maintained at 20uC
exhibited a severe growth defect over the course of the ten hour
induction period (Figure 1A). Western blot analysis of whole cell
lysate shows that Lpa production is sustained throughout the 20uC
induction and peaks at ten hours. At 37uC, production peaks at
four hours, and the decline in Lpa production after this time point
coincides with an increase in cell growth (Figure 1B). Thus, Lpa
is expressed in active form at both 37uC and 20uC, and its activity
at a range of temperatures suggests that it could be used as a probe
of in vivo lipoyl protein inactivation in organisms other than E. coli.
Because the accumulation of Lpa over a ten hour induction period
at 20uC results in an extended period of slow E. coli growth, in
subsequent assays we expressed Lpa at 20uC to take advantage of
the longer window of observation at this temperature.
Activity of Lpa in vivo
The biological role of Lpa in E. faecalis may rely on its ability to
recognize exogenous lipoylated peptides or proteins. We tested the
activity of Lpa against the three lipoylated proteins found in E. coli
(the H-protein of the glycine cleavage complex and the E2
subunits of pyruvate dehydrogenase and alpha-ketoglutarate
dehydrogenase) to determine whether the enzyme has a broad
specificity for lipoylated proteins. The lipoate auxotroph strain
KER176 was transformed with plasmids encoding wild type Lpa
(Lpa) or the active site nucleophile mutant Lpa S259A and grown
in a minimal media containing
35S-lipoate as the sole source of
lipoate, resulting in the incorporation of radiolabeled lipoate in the
three E. coli proteins. At an OD600 of 0.6, expression of Lpa and
Lpa S259A was induced with IPTG. After the induction period,
cell lysates were separated by SDS-PAGE and analyzed by
autoradiography. Incorporation of radiolabeled lipoate into the
three lipoylated enzymes in E. coli was greatly reduced in cells
expressing Lpa compared to cells expressing Lpa S259A
(Figure 2A). Analysis of the autoradiograph by densitometry
shows that lipoylation of the PDH E2, KDH E2, and H-protein in
cells expressing Lpa is reduced to 2%, 1%, and less than 1%,
respectively, of lipoylation in cells expressing Lpa S259A.
Figure 1. Lpa expression at 20 and 37uC. (A) Growth assay of E. coli
cells expressing lipoamidase at 20uC (open triangles) and 37uC (closed
triangles) relative to cells containing vector alone at 20uC (open circles)
and 37uC (closed circles). The OD600 of cultures was measured at the
time of induction with IPTG and then 2, 4, 6, and 10 hours post-
induction. Error bars represent the standard deviation of three
replicates. (B) Anti-His western blot of cells expressing Lpa at 20uC
and 37uC. Samples were taken from cultures at the time of induction
and at 2, 4, 6, and 10 hours post-induction.
doi:10.1371/journal.pone.0007392.g001
Figure 2. Uptake and incorporation of
35S-lipoic acid in the
presence of Lpa. (A) KER176 cells that are auxotrophic for lipoic acid
were transformed with plasmids encoding wild type Lpa (Lpa) or the
active site nucleophile mutant Lpa S259A and were grown in minimal
medium supplemented with
35S-lipoic acid. After a 10 hour induction at
20uC, cell samples were normalized by OD600 and protein extracts were
separated by SDS-PAGE and analyzed by autoradiography. The
assignment of the labeled species to the three lipoylated proteins in
E. coli, the PDH, KDH, and H-protein, is indicated. (B) Scintillation
counting was used to quantify
35S-lipoic acid taken up by the KER176
cultures shown in Figure 2A. Counts per minute (CPM) correspond to
the uptake of cells from 5 ml of culture with an OD600 of 1.1.
doi:10.1371/journal.pone.0007392.g002
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Prior evidence suggests that E. coli does not maintain large
intracellular stores of free lipoate. Herbert and Guest measured
PDH and KDH activities in E. coli extracts and found that these
enzymatic activities correlated well with the total cellular content of
lipoic acid, even when an excess of lipoic acid was added to the
growth medium [18]. These results suggest that either E. coli limits
the uptake of lipoic acid, or that the bacterium fails to retain excess
lipoic acid that is not needed to activate the two ketoacid
dehydrogenases. By densitometry analysis of the western blot in
Figure 2A, we determined that the total incorporation of lipoate
into proteins in cells expressing Lpa is 1% of that in cells expressing
Lpa S259A. We also measured
35S-lipoate in the lysates of KER176
cells expressing either Lpa or Lpa S259A, and found that cells
expressing the active enzyme contained 87% less
35S-lipoate than
cells expressing the inactive enzyme (Figure 2B). Together, these
results indicate that as Lpa cleaves lipoate from lipoylated proteins,
the free acid fails to accumulate in the cell.
Effect of Lpa on biotinylation
The broad substrate specificity of Lpa raises the possibility that
it could also cleave the amide bond linking biotin to the biotin-
carboxyl-carrier protein (BCCP) subunit of the acetyl-CoA
carboxylase (ACCase) found in E. faecalis and E. coli. In a bioassay,
Lpa was observed to cleave biotin from biotinyl-lysine [9];
therefore, we sought to determine whether Lpa also cleaves biotin
from proteins in vivo. The biotinylation status of the E. coli BCCP
(the sole biotinylated protein in E. coli) was monitored with
streptavidin-HRP. Cells expressing both Lpa and Lpa S259A
appeared to contain similar levels of biotinylated BCCP; however,
this level was markedly less than in cells expressing empty vector
(Figure 3A). Analysis of western blots by densitometry shows that
biotinylation of the BCCP in cells expressing Lpa and those
expressing Lpa S259A is approximately half the level of cells
expressing the empty vector, but that there is no significant
difference in biotinylation levels between cells expressing active
and inactive lipoamidase (Figure 3B). Expression of the BCCP in
E. coli is dependent on the cellular growth rate [19]; therefore, the
apparent difference in levels of biotinyl-BCCP is likely derived
from lower BCCP expression in cells expressing Lpa compared to
cells expressing the small peptide produced by the empty vector. In
general, the metabolic burden of protein over-expression typically
results in a significantly decreased replication rate. To confirm that
the decreased biotinylation of the BCCP was derived from protein
over-expression and was not Lpa-specific, we evaluated BCCP
biotin levels after the expression of two proteins: P. falciparum
malonyl-CoA:ACP acyltransferase (MCAT) and P. falciparum
ketoacyl-ACP synthase II (KASII). In both cases, we observed a
reduction in biotin levels similar to that observed in the cells
expressing Lpa (Figure 3C). Thus, it appears that decreased
biotinylation of BCCP is an artifact of protein over-expression and
that lipoamidase does not have significant biotinidase activity
against proteins in vivo.
Effect of Lpa and active site mutants on growth,
lipoylation, and biotinylation in vivo
Jiang and Cronan used a bioassay with the small molecule
substrate lipoyl-lysine to determine the activity of Lpa when
individual residues of the catalytic triad were mutated to alanine
[9]. Mutation of either of the two active site serines was found to
block lipoamidase activity, while mutation of the active site lysine
produced a partially active mutant. The effect of these mutations
on biotinyl-lysine cleavage was not determined. We compared the
effects of Lpa and the three active site mutants, the inactive Lpa
S235A and Lpa S259A and the partially active mutant Lpa
K159A, on growth, lipoylation, and biotinylation in E. coli. The
growth of cells expressing Lpa was severely compromised
compared to cells expressing the empty vector or the three active
site mutants (Figure 4A). Cells expressing the mutants did not
grow to the same OD600 as cells expressing vector alone, an
anticipated effect of protein over-expression. Interestingly, the
growth of cells expressing Lpa K159A did not significantly differ
from that of the two inactive serine mutants.
The dramatic growth defect observed with Lpa expression is
correlated with a severedecrease in lipoylation of the PDH and KDH
as observed by anti-lipoate western blot (Figure4B). Consistent with
ourpreviousobservations,nodifferenceinbiotinylationwasobserved
between cells expressing Lpa and any of the active site mutants
(Figure 4B). The E. coli PDH contains three lipoyl domains, in
contrast to the E. coli KDH, which contains a single lipoyl domain
and thus appears lighter than the PDH band [1]. The third lipoylated
protein in E. coli, the H-protein, is not detected by anti-lipoate western
blot. Expression of wild type Lpa reduced the lipoylation of the PDH
and KDH to 15% and 1%, respectively, of the levels in cells
expressing empty vector (Figure 4B and C). Expression of the
partially active mutant Lpa K159A produced a similar pattern of
lipoylation to that observed in the other two active site mutants. This
result is consistent with the similar growth rates observed in
Figure 4A and indicates that Lpa K159A enzymatic activity is not
significant enough to affect lipoylation in vivo.
Figure 3. Effect of protein expression on biotinylation. (A)
Affinity blot analysis of biotinylation in E. coli BL21 cells expressing Lpa
and Lpa S259A. Samples were normalized by OD600 and the protein
extracts from whole cell lysate were separated by SDS-PAGE and
blotted onto nitrocellulose. The biotinylation status of the BCCP, the
sole biotinylated protein in E. coli, was analyzed by streptavidin-HRP
western blot. (B) Densitometry analysis of the biotinylation level in cells
expressing Lpa and Lpa S259A. Streptavidin-HRP signal was normalized
to the HSP70 loading control signal for each sample. Within each blot,
the fraction of biotinylation relative to cells expressing vector alone was
determined. Error bars represent the SEM for fraction of biotinylation
for three independent western blots. (C) Affinity blot analysis of
biotinylation in E. coli BL21 cells expressing Lpa and the unrelated
proteins MBP-MCAT and MBP-KASII. Samples were analyzed by the
methods described in part A of this figure.
doi:10.1371/journal.pone.0007392.g003
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10% reduction in lipoyl-PDH and 25% reduction in lipoyl-KDH
compared to cells expressing empty vector (Figure 4C). This
could be attributable to either residual activity in all of the
mutants, or to lowered kdh and pdh expression in response to
metabolic stress from the over-expression of Lpa constructs. In E.
coli, pdh expression is repressed in response to the accumulation of
metabolites such as acetyl-CoA and NADH [20]. We examined
the activity of the Lpa active site mutants in a
35S-lipoic acid
incorporation assay that allowed us to observe lipoylation of the H-
protein as well as the PDH and KDH E2 subunits. The
incorporation of radiolabel into the E. coli PDH and KDH was
similar between the three active site mutants, while incorporation
of radiolabel into the H-protein was difficult to assess due to its low
signal (Figure 4D). Importantly,
35S-lipoic acid incorporation in
cells expressing the active site mutants was similar to that in cells
expressing the unrelated protein MBP-MCAT. Quantitative
analysis of three independent experiments shows that lipoylation
Figure 4. Growth, lipoylation, and biotinylation of cells expressing Lpa and Lpa active site mutants. (A) Growth assay of E. coli BL21 cells
expressing Lpa (open triangles) compared to vector alone (open circles) and the three active site mutants: Lpa K159A (open squares), Lpa S235A
(closed circles), and Lpa S259A (closed triangles). The OD600 of cultures was measured at the time of induction with IPTG and at 2, 4, 6, and 10 hours
post-induction. Error bars represent the standard deviation of three replicates from a representative growth assay. (B) Anti-lipoic acid and
streptavidin affinity blots to determine levels of PDH and KDH lipoylation and BCCP biotinylation in E. coli expressing empty vector, Lpa, and Lpa
active site mutants. (C) Densitometry analysis of PDH and KDH lipoylation in cells expressing Lpa and Lpa active site mutants. To determine the level
of KDH and PDH lipoylation, the anti-lipoic acid signal was normalized to the anti-HSP70 loading control signal. The fraction of lipoylation in cells
expressing Lpa or the Lpa active site mutants relative to cells expressing vector alone was then determined. Error bars represent the SEM for the
fraction of lipoylation for three independent western blots. (D) Autoradiograph of KER176 cells expressing vector alone, the Lpa active site mutants,
and MBP-MCAT grown in minimal medium supplemented with
35S-lipoic acid. After a 6 hour induction at 20uC, cell samples were normalized by
OD600 and protein extracts were separated by SDS-PAGE and analyzed by autoradiography. Equal sample loading was assessed by anti-HSP70
western blot.
doi:10.1371/journal.pone.0007392.g004
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among cells expressing the three active site mutants or between
cells expressing the mutants compared to cells expressing MBP-
MCAT (data not shown). These results confirm that the three Lpa
active site mutants do not have detectable lipoamidase activity,
and that lower lipoylation levels observed in cells expressing these
mutants are the result of metabolic stress associated with protein
induction.
Lpa toxicity in TM136 strain E. coli
The genes encoding the lipoate ligase (lplA) and the transferase
(lipB) are disrupted in TM136 strain E.coli, preventing protein
lipoylation [16]. Expression of Lpa in these cells will limit growth if
Lpa interferes with any important metabolic pathways other than
lipoylation. Expression of wild type Lpa in TM136 cells was
compared to the active site mutants Lpa S235A and Lpa S259A.
Triplicate cultures were initiated from an OD600 of 0.05 and
maintained in four different conditions: 37uC with and without
IPTG induction, and 20uC with and without IPTG induction.
Cultures maintained at 20uC( Figure 5, open symbols) grew more
slowly than their counterparts at 37uC( Figure 5, closed symbols),
however, there was no significant difference between cells
containing the Lpa plasmid versus those containing the active site
mutants. Induction of protein expression with 0.4 mM IPTG
slowed the growth of the cultures at both temperatures (Figure 5,
red symbols), but there was still no significant difference in growth
rate between cells expressing Lpa compared to those expressing
the mutants. These data demonstrate that Lpa is only toxic to E.
coli growth due to its lipoamidase activity, and that Lpa does not
interfere with other important metabolic pathways in E. coli.
Function and specificity of the amidase domain
Lpa is a two-domain protein, consisting of an amidase domain
and a domain of unknown function. The second domain is of low
complexity, and we explored whether the amidase domain alone
had aminohydrolase activity. Two truncation mutants were made
by introducing stop codons at codons 471 (Lpat471) and 521
(Lpat521) of the lpa gene. The Lpat471 mutant contains the
predicted amidase domain, whereas the Lpat521 mutant contains
an additional 50 residues of the second domain. When these
constructs were expressed in E. coli, the Lpat521 mutant did not
inhibit bacterial growth, whereas the Lpat471 mutant caused a
moderate growth defect less pronounced than that of wild type
Lpa (Figure 6A). Consistent with these effects on growth,
quantitative western blot analysis shows that the PDH and
KDH in cells expressing Lpat521 are lipoylated at 95% and 78% of
the empty vector level; these levels are similar to those observed in
cells expressing the active site mutants (Figure 4C). In contrast,
lipoylation in cells expressing Lpat471 dropped to 72% (PDH) and
24% (KDH) of empty vector levels, indicating that Lpat471 retains
some aminohydrolase activity (Figure 6B and C). Cells
expressing Lpat471 contain about three times the amount of
lipoylated PDH and KDH found in those expressing wild type
Lpa. The differences in lipoamidase activity between Lpa, Lpat471,
and Lpat521 are not attributable to differences in expression or
solubility. At 20uC, there appears to be a significant pool of soluble
Lpat521 despite the lack of apparent activity for this construct
(Figure 6D). The Lpat471 construct is soluble and well expressed
at both 20uC and 37uC, suggesting that this truncated form of Lpa
could be an improved tool over wild type Lpa for probing a-
ketoacid dehydrogenase inactivation in vivo. Biotinylation levels in
cells expressing Lpa, Lpat471, and Lpat521 were similar, indicating
that truncation of Lpa does not affect protein biotinylation
(Figure 6B).
Discussion
E. faecalis extracts containing lipoamidase have been used for
several decades as a tool to probe the role of lipoic acid in a-
ketoacid dehydrogenase enzymes [21–25]. Recently, Jiang and
Cronan identified the enzyme responsible for lipoamidase activity
and characterized the properties of this enzyme in vitro [9]. Cloning
of the lpa gene made it possible to use lipoamidase as a tool to
inactivate lipoylated enzymes in heterologous systems in vivo.I n
order to evaluate the effects of Lpa in vivo, we cloned the lpa gene
into an E. coli expression vector which appends a hexa-histidine tag
to the amino-terminus of Lpa. When expressed at 20uC, Lpa
inhibits bacterial growth over the course of the 10 hour induction
period (Figure 1). At 37uC, Lpa production peaked approxi-
mately four hours after induction, and normal bacterial growth
resumed shortly thereafter. While the amount of Lpa at six and ten
hours is diminished from the peak at four hours, a significant
amount of Lpa protein persists but does not adversely affect
bacterial growth. One possible explanation is that the lpa gene
accumulates loss of function mutations similar to those previously
observed [9], however, plasmids recovered from these experiments
did not contain mutations. A more likely explanation is that the
overall half-life of soluble, active Lpa is fairly short, and that the
sustained presence of protein after peak induction at 37uC is due to
the accumulation of insoluble and/or inactive protein. Indeed,
Figure 6D shows that relatively more insoluble Lpa has
accumulated after 4 hours at 37uC than after 10 hours at 20uC.
Activity at physiologic temperatures, as demonstrated here, is
crucial for the use of Lpa as an in vivo probe. In addition, the
relatively short window of lipoamidase activity at 37uCi sa n
attractive property since the activity of the probe could then be
more tightly controlled in a conditional expression system.
The usefulness of Lpa as an in vivo probe of a-ketoacid
dehydrogenase inactivation requires that the enzyme recognizes a
broad range of lipoylated proteins. We show that Lpa cleaves
radiolabeled lipoic acid from all three lipoylated proteins present
in E. coli (Figure 2). Two of these proteins, the PDH E2 and the
KDH E2, form very large multienzyme complexes that are several
million Daltons in size [26]. The third protein, the H-protein, is
approximately 14,000 Daltons, and does not form a stable
complex with all other GCV components [27]. Thus, Lpa activity
Figure 5. Growth of lipoylation deficient E. coli expressing Lpa
and Lpa active site mutants. Growth assay of TM136 strain cells [16]
expressing Lpa (squares), Lpa S235A (upward triangles), and Lpa S259A
(circles). Growth curves at 37uC (solid symbols) and 20uC (open symbols
are shown with cultures induced with 0.4 mM IPTG highlighted in red.
In each condition, the growth curve corresponding to cells expressing
wild type Lpa is shown with a thickened line.
doi:10.1371/journal.pone.0007392.g005
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multienzyme complex, but rather on the recognition of the
lipoylation domain shared by all lipoylated proteins.
The specificity of Lpa for lipoylated proteins versus other lysine
modifications was examined in early work using partially purified
E. faecalis extracts and small molecule moieties containing
functional groups or cofactors attached to lysine through an
amide bond [8]. These in vitro experiments showed that Lpa had a
strong specificity for lipoylated proteins and small molecules.
However, Lpa did hydrolyze e-N-biotinyl-L-lysine (biotinyl-lysine),
albeit at 2.5% the rate of e-N-lipoyl-L-lysine hydrolysis [9]. In vivo,
we did not detect hydrolysis of biotin from biotinylated proteins by
affinity blot (Figure 3). This result demonstrates that Lpa does not
have significant biotinidase activity in vivo, however, Lpa could
catalyze this reaction at a rate much lower than the rate of biotin
ligation. The opposite occurs for lipoylated proteins – Lpa cleaves
lipoate more rapidly than the rate at which the cell is able to
lipoylate proteins.
In a previous study, mutation of the Lpa active site residue
K159 to alanine was found to result in partial activity, while the
S235A and S259A mutants were found to be inactive [9]. We did
not observe a difference in the growth of E. coli cells expressing
these three Lpa active site mutations (Figure 4). Similarly, we did
not detect significant differences in the lipoylation of PDH or
Figure 6. Growth and lipoylation of Lpa constructs containing only the amidase domain. (A) Growth assay of E. coli cells expressing
Lpat471 (closed triangles) and Lpat521 (open squares) compared to expression of Lpa (open triangles) and vector alone (open circles). The OD600 of
cultures was measured at the time of induction with IPTG and at 2, 4, 6, and 10 hours post-induction. Error bars represent the standard deviation of
three replicates from a representative growth assay. (B) Anti-lipoic acid and streptavidin affinity blots to determine levels of lipoylation and
biotinylation in E. coli expressing empty vector, Lpa, and Lpa truncation mutants. (C) Densitometry analysis of PDH and KDH lipoylation in cells
expressing Lpa and Lpa truncation mutants. The fraction of lipoylation in cells expressing Lpa or the Lpa active site mutants relative to cells
expressing vector alone was determined as described in Figure 4C. Error bars represent the SEM for the fraction of lipoylation for three independent
western blots. (D) Solubility of Lpa and Lpa truncation mutants expressed at 20uC and 37uC. After induction of protein expression, cells were grown at
20uC for 10 hours or 37uC for four hours. Lpa in the insoluble (I) and soluble (S) fractions was analyzed by anti-His western blot.
doi:10.1371/journal.pone.0007392.g006
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the lipoylation of the H-protein (as determined by autoradiogra-
phy). These results indicate that the three active site mutations
have equivalent lipoamidase activity in our in vivo assays. Although
unlikely, it is possible that the three mutants have an equivalent
low level of lipoamidase activity. Indeed, this appears to be the
case based on the observation that cells harboring the empty
expression vector grow more rapidly and contain higher levels of
lipoylated proteins than cells harboring any of the three active site
mutants (Figure 4). This effect, however, is triggered by the
metabolic stress associated with protein expression, which is
largely absent from cells expressing only the empty vector. When
an unrelated protein (MCAT) was expressed, lipoylation was
indistinguishable from that observed with the three Lpa active site
mutants. Taken together, these results show that three Lpa active
site mutants do not have detectable activity in our in vivo assays.
Lipoamidase interferes with the lipoylation of all three lipoate
dependent proteins in E. coli, and it could also interfere with other
important metabolic pathways. To address this question, we assessed
the growth inhibition associated with expressing Lpa in an E. coli
strain which lacks lipoate metabolism. In strain TM136 E. coli,t h e
genes encoding lipoate ligase (lplA) and the lipoyl(ocantoyl)-acyl
carrier protein:protein transferase (lipB)a r ed i s r u p t e dt h r o u g h
transposon mutagenesis (lipB::Tn1000dKan lplA::Tn10) [16]. These
cells, which were a kind gift from John Cronan, do not contain
lipoylated proteins, but will grow in culture medium supplemented
with acetate and succinate to bypass the loss of lipoylated PDH and
KDH, respectively. We analyzed the growth of TM136 cells
transformed with plasmids encoding either Lpa or Lpa active site
mutants(Figure 5). The presence of Lpa did not decrease the growth
rate of these cells as compared to the active site mutants. This was
true at 37uCa n da t2 0 uC, regardless of whether protein expression
was induced with IPTG. These results prove that Lpa toxicity in E.
coli is solely manifest through interference with lipoate metabolism.
The carboxy-terminal domain of lipoamidase is not required for
activity. We generated a mutant Lpa truncated after the predicted
Figure 7. Lipoylation and biotinylation sites. (A) Amino acid sequence alignments of lipoylation and biotinylation sites in E. coli. The lysine that
is involved in lipoic acid or biotin attachment is marked in bold. Residues corresponding to conserved glycine and glutamine residues are shaded
[33]. Residues forming the biotinylation consensus site are underlined. (B) ClustalW comparison of amino acid sequences surrounding the site of
lipoate attachment for lipoylated proteins found in E. faecalis. The substitution of the Glu three residues amino-terminal to the lipoyl lysine with Gln
(underlined residues) is a common motif in the BCDH E2.
doi:10.1371/journal.pone.0007392.g007
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partial growth defect and retained Lpa activity as tested by anti-
lipoate western blot, however, a variant extending to residue 521
(Lpat521) did not interfere with growth or lipoylation (Figure 6).
This construct is expressed at levels similar to those observed with
Lpat471 and it is only slightly less soluble. Perhaps the additional 50
amino acids in the Lpat521 construct interfere with substrate
binding, limiting its activity in vivo. Growth assays and western blot
analysis show that Lpat471 is less active than wild type Lpa;
however, its activity is sufficient to cause a growth defect and
measurable decrease in lipoylation, making Lpat471 a potentially
useful probe in other organisms. Importantly, truncation of the
carboxy-terminal domain does not affect protein biotinylation,
suggesting that the second domain is not essential for activity or
specificity. The smaller size of Lpat471 may make it more amenable
to expression in heterologous systems.
Two factors may allow Lpa to discriminate between lipoylated
proteins and biotinylated proteins despite the fact that the
cofactors are similar in structure and the proteins that they are
attached to share the same protein fold. NMR structures of the E.
coli BCCP show that the biotin cofactor is sequestered by a thumb-
like region [28], making the biotin-amide bond less accessible to
Lpa than on biotinyl-lysine. Also, the residues immediately
surrounding the biotinylation site are well conserved among
biotinylated proteins, and distinct from those found in analogous
positions in lipoylated proteins (Figure 7A). These residues help
biotin ligases and lipoate ligases to discriminate between possible
substrates and may be important for lipoamidase specificity as
well. Substitution of the MKM motif found in the E. coli BCCP
with a sequence commonly found in lipoylated proteins (DKA)
resulted in partial lipoylation of the BCCP [29]. Mutation of the
residue preceding the biotinylation site in yeast pyruvate
carboxylase 1 compromises biotinylation [30]. Similarly, mutation
of the glutamate three residues before the lipoylation site to
glutamine in human PDH prevents lipoylation [31].
The role that lipoamidase plays in E. faecalis is not clear. Genes
encoding PDH, BCDH and H-protein can all be found in the E.
faecalis genome, however, lipoate is not required for anaerobic
growth when a sufficient source of fermentable material is available
[32]. Under conditions favoring aerobic growth, lipoylation of PDH
and BCDH may be important. It is interesting to note that the
residues found in the E. faecalis PDH and BCDH lipoylation
domains are distinct from those found in other organisms, while the
residues found in the E. faecalis H-protein are identical to other
organisms at the conserved amino acid sites (Figure 7B). As in E.
coli,i nE. faecalis the H-protein may not be necessary for growth
under aerobic conditions, and the use of divergent lipoylation site
sequences for the PDH and BCDH may help to limit the activity of
lipoamidase against these proteins in E. faecalis.
Lipoamidase is a potentially useful tool for probing the role of
lipoylation in vivo. Lpa inactivates a broad range of lipoylated
proteins and does not seem to interfere with any other important
metabolic pathways in E. coli. The mutant K159A, which is
partially active in vitro, did not show detectable activity in vivo,
indicating that the three active site mutants, K159A, S235A, and
S259A, can be used as inactive controls in an in vivo experiment.
Lpa activity can be tightly controlled by a conditional expression
system and may be especially useful in probing lipoate metabolism
in organisms in which gene disruptions and gene knockdowns are
impractical or impossible. A major limitation of Lpa as an in vivo
probe is whether the organism of interest is able to express Lpa
because of its large size and the low complexity of the second
domain. The engineering of Lpat471 reduces the length of Lpa by
259 amino acids and increases the chance that the probe can be
expressed in active form in heterologous systems. Taken together,
these studies in E. coli demonstrate how lipoamidase can be
employed to probe lipoate metabolism in vivo.
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